Get the latest direct to your inbox twice a week. Sign up today. 
BCG2 Health and Spitfire’s Pfizer ‘FACTORy’ wins award
BCG2 Health’s Pfizer ‘FACTORy’ programme, originally developed in New Zealand in collaboration with Spitfire, and then launched into Australia, has won a Pfizer Human Health global award for commercial excellence and innovation.
Pfizer ‘FACTORy’ is a support programme linking health care professionals and their patients. Pfizer ‘FACTORy’ helps monitor a hemophiliac patient’s condition and treatment, through an i-Phone app that records and transmits medical information through a secure online database to their health care professional. There have been expressions of interest to adapt the platform for other markets.
“It’s a huge win for our New Zealand and Australian client, and great recognition for our agency efforts as well. It’s also a great example of how locally produced innovations and ideas can compete and win on a world stage,” says BCG2 Health’s general manager Stuart Ogden.
